ClinicalTrials.gov
ClinicalTrials.gov Menu

Intensive Versus Traditional Voice Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03129880
Recruitment Status : Recruiting
First Posted : April 26, 2017
Last Update Posted : August 14, 2017
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison

Brief Summary:
The purpose of this study is to determine if there are differences in treatment outcomes between traditional voice therapy, performed weekly for a maximum of 6 weeks versus intensive voice therapy, consisting of 4-6 therapy sessions performed within one day.

Condition or disease Intervention/treatment Phase
Dysphonia Behavioral: Weekly Voice Therapy Behavioral: Intensive Voice Therapy Not Applicable

Detailed Description:

The goal of voice therapy is optimal long-term vocal quality and communication function with minimal recurrence. Traditional voice therapy for dysphonia typically consists of one to two therapy sessions each week with a single clinician for about 8 weeks. Another approach of voice therapy is intensive short-term therapy also known as "boot camp." This approach, borrows from the disciplines of neurobiology, exercise physiology, motor learning, and psychotherapy which describe desirable learning and behavior changes influenced by practice that involves high-intensity overload, variability, and specificity of training. A few studies have showed that "Boot Camp" model of intensive therapy resulted in comparable gains in voice quality and vibratory mechanics and may promote better patient satisfaction and attendance.

While such findings support the notion that intensive voice therapy may enhance voice therapy outcomes, no study to date has examined patient response to the "Boot Camp" approach to voice therapy. The investigators will compare the outcomes of traditional, weekly voice therapy and intensive voice therapy with multiple sessions in one day.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 73 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

For purposes of this study participants will be randomized into one of the following two groups:

4-6 weekly standard of care therapy sessions, once a week, for a maximum of six weeks 4-6 standard of care therapy sessions in one day Standard of care treatment may continue past patient enrollment in this study.

Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Voice-related Outcomes in Response to Intensive Versus Traditional Therapy Programs
Actual Study Start Date : March 13, 2016
Estimated Primary Completion Date : March 12, 2021
Estimated Study Completion Date : March 12, 2021

Arm Intervention/treatment
Placebo Comparator: Weekly Voice Therapy
Participants are randomized to receiving weekly voice therapy sessions
Behavioral: Weekly Voice Therapy
Participants will be randomized to receive weekly voice therapy

Active Comparator: Intensive Voice Therapy
Participants are randomized to receiving multiple sessions of voice therapy in one day
Behavioral: Intensive Voice Therapy
Participants will be randomized to receive multiple sessions of voice therapy in one day.




Primary Outcome Measures :
  1. Self-efficacy and readiness scale Changes [ Time Frame: Baseline compared to Immediately post voice therapy ]
    Pre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)

  2. Self-efficacy and readiness scale Change [ Time Frame: Baseline compared to 12 weeks post voice therapy ]
    Pre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 59 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed with a Voice disorder
  • Diagnosed with benign vocal fold lesions and/or hyper-function
  • First/primary propose treatment modality is voice therapy
  • Patients who are appropriate for either standard of care treatment modality (traditional or intensive voice therapy)
  • Willingness to participate in either standard of care treatment modality
  • All races
  • Males and females
  • English speaking

Exclusion Criteria:

  • Younger than 18
  • Older than 59
  • Inability or unwillingness to participate in one of the standard of care treatment modalities
  • Laryngeal Surgery or procedures during course of study
  • Prisoners

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03129880


Contacts
Contact: Emerald J Doll, MS, CCC-SLP 608-262-5213 doll@surgery.wisc.edu
Contact: Katherine McConville, MA, CCC-SLP 608-263-4864 mcconville@surgery.wisc.edu

Locations
United States, Wisconsin
University of Wisconsin-Madison Voice and Swallow Clinic Recruiting
Madison, Wisconsin, United States, 53792
Contact: Emerald Doll, MS    608-262-5213    doll@surgery.wsic.edu   
Principal Investigator: Emerald Doll, MS         
Sub-Investigator: Katherine McConville, MA         
Sponsors and Collaborators
University of Wisconsin, Madison

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT03129880     History of Changes
Other Study ID Numbers: 2015-0763
First Posted: April 26, 2017    Key Record Dates
Last Update Posted: August 14, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Wisconsin, Madison:
Voice disorder
Hoarseness
Phonation Disorders
Speech Disorders

Additional relevant MeSH terms:
Dysphonia
Voice Disorders
Laryngeal Diseases
Respiratory Tract Diseases
Otorhinolaryngologic Diseases
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms